Skip to main content

Alaunos Therapeutics, Inc PRE 14A, filed Nov 13, 2026

Alaunos Therapeutics, Inc. (TCRT)

Alaunos Therapeutics, Inc. asks 2027 stockholders to approve redomestication from Delaware to the Cayman Islands, a reverse split ranging from one new share for every two shares to one for every ten, and an authorized-share increase from 50,000,000 to 400,000,000. AI summary

PRE 14A 2026-11-13 For: 2026-11-13
View Original
Added on November 13, 2026